Implications of the ageing population for radiation oncology: cost-effectiveness

被引：0
|
作者：
Van Loon, J. [1 ]
机构：
[1] MAASTRO Clin, Radiat Oncol, Maastricht, Netherlands
来源：
RADIOTHERAPY AND ONCOLOGY | 2018年 / 127卷
关键词：
D O I：
10.1016/S0167-8140(18)30980-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SP-0670
引用
收藏
页码：S354 / S354
页数：1
相关论文
共 50 条
  • [41] THE IMPLICATIONS OF COST-EFFECTIVENESS FOR AUTOLOGOUS BLOOD PROCUREMENT
    ADEGBOYEGA, PA
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1994, 118 (12) : 1168 - 1168
  • [42] Cost, Effectiveness, and Cost-Effectiveness
    Diamond, George A.
    Kaul, Sanjay
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2009, 2 (01): : 49 - 54
  • [43] Cost-effectiveness of sumatriptan in a managed care population
    Legg, RF
    Sclar, DA
    Nemec, NL
    Tarnai, J
    Mackowiak, JI
    AMERICAN JOURNAL OF MANAGED CARE, 1997, 3 (01): : 117 - 122
  • [44] Cost-effectiveness of population genomic screening Response
    Lacaze, Paul
    Tiller, Jane
    Bao, Yining
    Riaz, Moeen
    Winship, Ingrid
    Zhang, Lei
    GENETICS IN MEDICINE, 2019, 21 (12) : 2842 - 2843
  • [45] Stochastic cost-effectiveness analysis on population benefits
    Ermo Chen
    Cost Effectiveness and Resource Allocation, 21
  • [46] Stochastic cost-effectiveness analysis on population benefits
    Chen, Ermo
    COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2023, 21 (01)
  • [47] Cost-effectiveness profiles with an expanding treatment population
    Langley, PC
    CLINICAL THERAPEUTICS, 1995, 17 (06) : 1207 - 1212
  • [48] THE COST-EFFECTIVENESS OF MEDICAL SCREENING IN A WORKING POPULATION
    SCHWARTZ, DA
    ROSENSTOCK, L
    HEYER, NJ
    BARNHART, S
    CLINICAL RESEARCH, 1986, 34 (02): : A382 - A382
  • [49] Cost-effectiveness of population screening for aortic stenosis
    Motazedian, Pouya
    Prosperi-Porta, Graeme
    Hibbert, Benjamin
    Jalal, Hawre
    Labinaz, Marino
    Burwash, Ian G.
    Abdel-Razek, Omar
    Di Santo, Pietro
    Simard, Trevor
    Wells, George
    Coyle, Doug
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2024,
  • [50] EVALUATING THE COST-EFFECTIVENESS OF NEXTGENERATION SEQUENCING AS A BIOMARKER TESTING STRATEGY IN ONCOLOGY AND IMPLICATIONS FOR POLICY: A LITERATURE REVIEW
    Wilsdon, T.
    Mirza, M.
    Goerke, L.
    VALUE IN HEALTH, 2023, 26 (12) : S62 - S62
12345